Guests: Kevin O'Neill
Coming Up Short
August 9, 2017
Kevin O’Neill leads off the show with a quick recap of the Stocks & Jocks softball team’s championship game loss before talking inflation, healthcare and more. Fari Hamzei of Hamzei Analytics assesses the risk of North Korea after its latest series of threats. David Andalman of PTI Securities & Futures talks $DIS, $NFLX and more.
Chiefapalooza
August 4, 2017
Kevin O’Neill kicks off the show talking ‘pay-for-play’ politics, President Trump’s ties to Russia and the groups most negatively affected by the Affordable Care Act. Kathy Dervin is in-studio with special guests Julie Dervin and Meghan Skelton. Chief and the ladies discuss both the positive and negative impact a festival like Lollapalooza has on the city of Chicago. John Neal of PTI Securities & Futures’ Peoria, AZ location joins the music discussion before breaking down the labor report.
16 Days Fit Into Two Hours
August 3, 2017
Denver labor attorney Lou Michels calls in for hour one. Chief and Lou are joined in the first segment by Kevin O’Neill to reflect on the late Ara Parseghian. The guys also discuss Russia, the Trump administration and much more. VIX, SPX and RUT guru Russell Rhoads of the CBOE joins the Chief for hour two to discuss trading strategies, bull markets and a new open outcry exchange opening in Chicago.
Good Government is Good Politics
August 2, 2017
Kevin O’Neill leads off. Chief and Kevin cover everything from business operations and the war in Iraq, to the inefficiency of government and healthcare policy. Fari Hamzei of Hamzei Analytics predicts a tough road ahead for President Trump and the Republican party. David Andalman of PTI Securities & Futures tells us why he’s bearish on $NFLX.
Aging Arguments
July 26, 2017
Kevin O’Neill leads off the show with a continuation of last week’s healthcare discussion. Fari Hamzei of Hamzei Analytics has lost all confidence in the Trump Administration. David Andalman of PTI Securities & Futures debates the state of the Chicago Blackhawks before talking $GM and their inability to compete with tech stocks.
